Article Details
Retrieved on: 2020-12-18 22:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported $0.40 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.28 by $0.12.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here